Levy M - Search Results

1

Multiple types of relapses in MOG antibody disease.

Levy M, Molazadeh N, Bilodeau PA, Vishnevetsky A, Lotan I, Salky R, Anderson M, Romanow G, Lechner-Scott J, Yeh EA, Giovannoni G. Levy M, et al. Mult Scler Relat Disord. 2023 Apr;72:104613. doi: 10.1016/j.msard.2023.104613. Epub 2023 Mar 12. Mult Scler Relat Disord. 2023. PMID: 36931080 No abstract available.

2

The biological rabbit hole: Only for the blind.

Hawkes CH, Giovannoni G, Lechner-Scott J, Levy M, Yeh A. Hawkes CH, et al. Among authors: levy m. Mult Scler Relat Disord. 2022 Nov;67:104256. doi: 10.1016/j.msard.2022.104256. Epub 2022 Oct 18. Mult Scler Relat Disord. 2022. PMID: 36302291 No abstract available.

3

Upregulated complement receptors correlate with Fc gamma receptor 3A-positive natural killer and natural killer-T cells in neuromyelitis optica spectrum disorder.

Nishiyama S, Wright AE, Lotan I, Mikami T, Paul F, Aoki M, Levy M. Nishiyama S, et al. Among authors: levy m. J Neuroinflammation. 2022 Dec 12;19(1):296. doi: 10.1186/s12974-022-02661-1. J Neuroinflammation. 2022. PMID: 36503481 Free PMC article.

4

Quantifying the economic burden to patients of relapse events from neuromyelitis optica spectrum disorders: A cross-sectional survey.

Rice DR, Holroyd KB, Pua DK, Levy M, Mateen FJ, Bhattacharyya S. Rice DR, et al. Among authors: levy m. Mult Scler Relat Disord. 2023 Mar;71:104580. doi: 10.1016/j.msard.2023.104580. Epub 2023 Feb 15. Mult Scler Relat Disord. 2023. PMID: 36805175

5

Migraine and multiple sclerosis: The final answer?

Hawkes CH, Giovannoni G, Lechner-Scott J, Levy M, Yeh A. Hawkes CH, et al. Among authors: levy m. Mult Scler Relat Disord. 2023 Jun;74:104769. doi: 10.1016/j.msard.2023.104769. Epub 2023 May 23. Mult Scler Relat Disord. 2023. PMID: 37270888 No abstract available.

6

Electrophysiological and Histological Correlations of Optic Neuritis in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis.

Lotan I, Nishiyama S, Wright A, Myoung Seok J, Levy M. Lotan I, et al. Among authors: levy m. Neuroscience. 2023 Aug 1;524:89-93. doi: 10.1016/j.neuroscience.2023.05.027. Epub 2023 Jun 7. Neuroscience. 2023. PMID: 37290683

7

Is using ChatGPT to help write papers and grants is useful, and ethical?

Levy M, Yeh A, Hawkes C, Lechner-Scott J, Giovannoni G. Levy M, et al. Mult Scler Relat Disord. 2023 Aug;76:104873. doi: 10.1016/j.msard.2023.104873. Epub 2023 Jul 5. Mult Scler Relat Disord. 2023. PMID: 37422957 No abstract available.

8

Is it ethical to use teriflunomide as an active comparator in phase 3 trials?

Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Yeh EA. Giovannoni G, et al. Among authors: levy m. Mult Scler Relat Disord. 2023 Oct;78:104911. doi: 10.1016/j.msard.2023.104911. Epub 2023 Jul 27. Mult Scler Relat Disord. 2023. PMID: 37582327 Review.

9

CNS resilience in the progression of MS.

Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Ann Yeh E. Giovannoni G, et al. Among authors: levy m. Mult Scler Relat Disord. 2023 Sep;77:104937. doi: 10.1016/j.msard.2023.104937. Epub 2023 Aug 19. Mult Scler Relat Disord. 2023. PMID: 37634271

10

Can we improve outcomes in MS around the world? Access and global considerations across income strata.

Yeh EA, Giovannoni G, Hawkes C, Levy M, Lechner-Scott J. Yeh EA, et al. Among authors: levy m. Mult Scler Relat Disord. 2023 Nov;79:105086. doi: 10.1016/j.msard.2023.105086. Epub 2023 Oct 19. Mult Scler Relat Disord. 2023. PMID: 37871481 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,029 results

Search Page

Filters